Joseph Solomkin, MD, on the Results From the IGNITE4 Trial
10/18/2016
In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.
Additional Reading:
- Solomkin JS, Gardovskis J, Lawrence K, et al. IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections. Clin Infect Dis. 2019;69(6):921-929. https://doi.org/10.1093/cid/ciy1029.
Joseph Solomkin, MD, is a Professor of Surgery Emeritus at the University of Cincinnati in Ohio. He is also a consultant for Tetraphase, the pharmaceutical company that produces eravacycline.